Sidney Taurel, the chairman and CEO of Eli Lilly, has a story and some advice:
Tuesday, November 27, 2007 :::
For the media, if I may be so bold: Don't trade in leaks and rumors where scientific data are concerned. Damage to public understanding is hard to repair after it's been done. Wait for real numbers, and take the time to explain statistics and benefit-risk analysis, which cannot be conveyed in sound bites alone. And for would-be pundits: If you have not had firsthand exposure to the scientific results or specialized knowledge under discussion, then qualify your comments if you must make them at all.Good luck, Mr. Taurel.
::: posted by Steven at 9:10 PM